CXCR3 and injury: In the present study, we indicated that single and repeated intrathecal administration of CXCR2 (NVP CXCR2 20) and CXCR3 ((±)-NBI 74330) antagonists resulted in a strong and persistent dose-dependent analgesic effect 7 days after nerve injury in rats.